The economic impact of applying steps as a tool for rational drug selection

• In: SIG Pharmacoeconomics/Pharmacoepidemiology - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: PP-P-004
• By: ALAHDAB AHMED, Ola (Queens University of Belfast, Belfast, United Kingdom)
• Co-author(s): Crealey, Grainne (Clinical Research Support Centre, BELFAST, United Kingdom)
  Scott, Michael (United Hospital Trust, ANTRIM, United Kingdom)
  Mairs, Jill (Whiteabbey Hospital, NEWTOWNABBEY, United Kingdom)
  Johnston, D (Queens University of Belfast, BELFAST, United Kingdom)
  Nichols, P (Royal Victoria Hospital, BELFAST, United Kingdom)
  Mc Elnay, James (Queens University of Belfast, BELFAST, United Kingdom)
  
• Abstract:

  Introduction: Spend on prescription medicines is one of the fastest growing cost components of modern health care systems, increasing by 10-12% per annum in the UK, USA, and Canada. Drug formularies are used to protect against high medicine costs, and to provide prescribers with a range of safe and appropriate products with demonstrated..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login